Nuveen Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-213,362
| Closed | -$17.7M | – | 3242 |
|
2022
Q3 | $17.7M | Sell |
213,362
-7,333
| -3% | -$610K | 0.01% | 1100 |
|
2022
Q2 | $18.3M | Buy |
220,695
+24,177
| +12% | +$2.01M | 0.01% | 1096 |
|
2022
Q1 | $23M | Sell |
196,518
-2,941
| -1% | -$344K | 0.01% | 1105 |
|
2021
Q4 | $21M | Sell |
199,459
-21,597
| -10% | -$2.27M | 0.01% | 1206 |
|
2021
Q3 | $29.8M | Sell |
221,056
-8,460
| -4% | -$1.14M | 0.01% | 997 |
|
2021
Q2 | $22.3M | Buy |
229,516
+5,407
| +2% | +$525K | 0.01% | 1277 |
|
2021
Q1 | $15.3M | Sell |
224,109
-147,324
| -40% | -$10.1M | ﹤0.01% | 1517 |
|
2020
Q4 | $31.8M | Buy |
371,433
+95,799
| +35% | +$8.21M | 0.01% | 948 |
|
2020
Q3 | $17.9M | Sell |
275,634
-25,496
| -8% | -$1.66M | 0.01% | 1121 |
|
2020
Q2 | $22M | Buy |
301,130
+116,876
| +63% | +$8.54M | 0.01% | 983 |
|
2020
Q1 | $6.27M | Sell |
184,254
-280,553
| -60% | -$9.55M | ﹤0.01% | 1578 |
|
2019
Q4 | $25.3M | Sell |
464,807
-402,265
| -46% | -$21.9M | 0.01% | 1038 |
|
2019
Q3 | $36.2M | Sell |
867,072
-18,953
| -2% | -$791K | 0.01% | 824 |
|
2019
Q2 | $38.8M | Buy |
+886,025
| New | +$38.8M | 0.02% | 814 |
|